Coffee and myocardial infarction.

Association of coffee drinking with total and cause-specific mortality. N Engl J Med (2012) 5.31

Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03

Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation (2013) 1.45

A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer (1976) 1.32

Is milk a coronary health hazard? Br J Prev Soc Med (1977) 1.23

Bladder cancer mortality in diabetics in relation to saccharin consumption and smoking habits. Br J Prev Soc Med (1975) 1.16

Coffee and tea consumption and the prevalence of coronary heart disease in men and women: results from the Scottish Heart Health Study. J Epidemiol Community Health (1993) 1.13

Diet in the pathogenesis of ischaemic heart disease. Postgrad Med J (1976) 1.03

Clustering of atherogenic behaviors in coffee drinkers. Am J Public Health (1990) 0.94

Nutritional recommendations for cardiovascular disease prevention. Nutrients (2013) 0.94

Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West J Med (1992) 0.91

Regular aspirin intake and acute myocardial infarction. Br Med J (1974) 0.87

Consumption of coffee or tea and symptoms of anxiety. Am J Public Health (1984) 0.82

Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers. Cancer Epidemiol Biomarkers Prev (2015) 0.81

Coffee Drinking Is Widespread in the United States, but Usual Intake Varies by Key Demographic and Lifestyle Factors. J Nutr (2016) 0.80

Cardiovascular complications from consumption of high energy drinks: recent evidence. J Hum Hypertens (2014) 0.78

Coffee and coronary disease. J R Coll Gen Pract (1987) 0.75

Headaches and coffee. Br Med J (1977) 0.75

Coffee consumption and mortality in a community study--Evans Co., Ga. Z Ernahrungswiss (1976) 0.75

Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med (1987) 13.50

Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst (1982) 13.25

Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31

Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol (1974) 9.27

Evidence on screening for breast cancer from a randomized trial. Cancer (1977) 7.91

Clinical prediction rules. Applications and methodological standards. N Engl J Med (1985) 7.72

Estimation of relative risk from individually matched series. Biometrics (1970) 6.47

Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40

Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02

Periodic breast cancer screening in reducing mortality from breast cancer. JAMA (1971) 5.91

Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43

Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes (1965) 5.42

Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40

Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96

Antidepressants and suicide. BMJ (1995) 4.84

Stratification by a multivariate confounder score. Am J Epidemiol (1976) 4.58

Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52

Confounding: essence and detection. Am J Epidemiol (1981) 4.47

The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med (1994) 4.41

Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39

Standardization of risk ratios. Am J Epidemiol (1972) 4.32

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21

Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet (1997) 4.19

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07

HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91

Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71

The reluctant participant in a breast cancer screening program. Public Health Rep (1968) 3.60

Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55

A comparison of the requirements for primary care physicians in HMOs with projections made by the GMENAC. N Engl J Med (1986) 3.54

Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48

Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40

Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35

Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34

Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33

The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32

Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20

Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18

Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04

Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet (1990) 3.03

An alternative to the proportionate mortality ratio. Am J Epidemiol (1981) 3.03

The need for randomization in the study of intended effects. Stat Med (1984) 3.01

Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99

Concern Early lung cancer action project: initial findings on repeat screenings. Cancer (2001) 2.99

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96

Comprehensive drug surveillance. JAMA (1970) 2.92

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89

Mammography and clinical examination in mass screening for cancer of the breast. Cancer (1967) 2.80

Functional recovery and medical costs of trauma: an analysis by type and severity of injury. J Trauma (1988) 2.74

Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69

Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology (1987) 2.68

Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr (1983) 2.65

Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65

Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65

The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64

Individual matching with multiple controls in the case of all-or-none responses. Biometrics (1969) 2.58

Induction of an active transport system for glucose 6-phosphate in Escherichia coli. Arch Biochem Biophys (1966) 2.53

Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50

Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49

A case-control study of baldness in relation to myocardial infarction in men. JAMA (1993) 2.49

Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43

The estimation of oxygen consumption. Cardiovasc Res (1970) 2.40

Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol (1979) 2.40

Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39

Noninvasive tests in the initial evaluation of heart murmurs in children. N Engl J Med (1983) 2.39

Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38

Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health (1972) 2.35

Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35

Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34

Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34

Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30

The discovery of drug-induced illness. N Engl J Med (1977) 2.29

Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (1995) 2.25

Components of the crude risk ratio. Am J Epidemiol (1972) 2.25

Current practice of artificial insemination by donor in the United States. N Engl J Med (1979) 2.24

Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22

Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21

Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. N Engl J Med (1980) 2.20

Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18

The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17

Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol (2003) 2.17